DAMALI MUWONGE: Open Payments
NPI 1710684212 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,169 in 139 payments from 22 companies in 2025. Trend: 2023 $2,111 · 2024 $2,526 · 2025 $3,169
Food & beverage: $3,069Education: $100
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 12 | $305 |
| HARMONY BIOSCIENCES LLC | 9 | $266 |
| GlaxoSmithKline, LLC. | 10 | $244 |
| Axsome Therapeutics, Inc. | 11 | $242 |
| Insmed, Inc. | 10 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $198 |
| Regeneron Healthcare Solutions, Inc. | 9 | $198 |
| AstraZeneca Pharmaceuticals LP | 9 | $198 |
| Grifols USA, LLC | 7 | $185 |
| Avadel CNS Pharmaceuticals, LLC | 8 | $160 |
Products named: DUPIXENT, XYWAV, WAKIX, Sunosi, Arikayce, TRELEGY ELLIPTA, GLASSIA, Prolastin-C Liquid.
Industry payments across AL — which companies pay providers there.
